Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria

被引:56
作者
Ackermann, G
Schaumann, R
Pless, B
Claros, MC
Goldstein, EJC
Rodloff, AC
机构
[1] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, D-04109 Leipzig, Germany
[2] Santa Monica UCLA Med Ctr, RM Alden Res Lab, Santa Monica, CA 90404 USA
关键词
D O I
10.1007/s100960050465
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The antimicrobial activity of moxifloxacin and seven other antibiotics (four of them quinolones) against 292 strains of obligately anaerobic bacteria was assessed employing a broth microdilution technique performed in Wilkens-Chalgren broth. MIC50/MIC90 values (mg/l) for moxifloxacin were as follows: Bacteroides fragilis (n=62) 0.25/2, Bacteroides ovatus (n=70) 1/4, Bacteroides vulgatus (n=29) 0.25/1, Bacteroides thetaiotaomicron (n=17) 2/2, Bacteroides caccae (n=11) 1/2, Prevotella spp. (n=11) 0.25/2, Fusobacterium spp. (n=17) 1/4, Bilophila wadsworthia (n=29) 0.5/1, and Clostridium spp. (n=29) 0.125/0.5, respectively. MIC50/MIC90 values (mg/l) for Bacteroides distasonis (n=8) and Peptostreptococcus spp. (n=9) were 0.25. The results indicated that moxifloxacin was almost as active as trovafloxacin, as active as gatifloxacin, and more active than levofloxacin and ciprofloxacin against the anaerobes tested.
引用
收藏
页码:228 / 232
页数:5
相关论文
共 15 条
[1]   Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes [J].
Aldridge, KE ;
Ashcraft, DS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :709-711
[2]   Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect [J].
Boswell, FJ ;
Andrews, JM ;
Wise, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1377-1379
[3]  
CLAROS MC, 1996, CLIN INFECT DIS, V23, P66
[4]  
CLAROS MC, IN PRESS ANAEROBE
[5]  
*DIN, 1999, MED MIKR IMM NORM WE
[6]   Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria [J].
Edlund, C ;
Sabouri, S ;
Nord, CE .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (03) :193-195
[7]  
GARAFFO R, 1998, 38 INT C ANT AG CHEM, P39
[8]  
LOZA E, 1998, 38 INT C ANT AG CHEM, P229
[9]   Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria [J].
MacGowan, AP ;
Bowker, KE ;
Holt, HA ;
Wootton, M ;
Reeves, DS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) :503-509
[10]  
National Committee for Clinical Laboratory Standard, 1997, M11A4 NCCLS